1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-126382
    Hesperidin methylchalcone Inhibitor ≥98.0%
    Hesperidinmethylchalcone (Hesperidinmethylchalcone) 是一种口服活性黄酮类化合物,具有镇痛、抗炎和抗氧化特性。Hesperidin methylchalcone 具有血管保护活性。Hesperidin methylchalcone 抑制氧化应激、细胞因子产生和 NF-κB 激活。Hesperidin methylchalcone 可用于痛风疾病的研究。
    Hesperidin methylchalcone
  • HY-14592
    Tectochrysin

    柚木柯因

    Inhibitor 99.88%
    Tectochrysin (Techtochrysin) 是 Alpinia oxyphylla 的主要黄酮类化合物之一。 Tectochrysin 抑制 NF-κB 活性。
    Tectochrysin
  • HY-124179
    IT-901 Inhibitor ≥99.0%
    IT-901 是一种具有口服活性且有效的 NF-κB 亚基 c-Rel 抑制剂,对 NF-κBc-Rel 与 DNA 结合的 IC50 分别为 0.1 μM,3 μM。IT-901 是一种具有生物活性的萘硫代巴比妥酸酯衍生物,具有用于人类淋巴瘤和改善移植物抗宿主病 (GVHD) 的潜力。
    IT-901
  • HY-P1832A
    PTD-p65-P1 Peptide TFA Inhibitor 99.14%
    PTD-p65-P1 Peptide TFA 是一种有效的选择性核转录因子 NF-κB 抑制剂,来源于 NF-κB 氨基酸残基 271-282 的 p65 亚单位,可选择性抑制各种炎症刺激诱导的 NF-κB 激活,下调 NF-κB 介导的基因表达,并上调细胞凋亡(apoptosis)。
    PTD-p65-P1 Peptide TFA
  • HY-B0185R
    Lidocaine (Standard)

    利多卡因(标准品)

    Inhibitor 99.85%
    Lidocaine (Standard) 是 Lidocaine 的分析标准品。本产品用于研究及分析应用。Lidocaine (Lignocaine) 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,可用于研究室性心律失常。
    Lidocaine (Standard)
  • HY-N1486
    Ursonic acid

    熊果酮酸

    Inhibitor 98.15%
    Ursonic acid 是一种天然的三萜酸,具有口服活性。Ursolic acid 可以通过多种信号通路诱发人类癌症细胞的细胞凋亡。Ursolic acid 具有抗炎和抗癌活性。
    Ursonic acid
  • HY-N2908
    Atraric acid Inhibitor 99.94%
    Atraric acid (Methyl atrarate) 是一种特异的雄激素受体 (androgen receptor) 拮抗剂,具有抗炎和抗癌作用。Atraric acid 抑制 LNCaP 和 C4-2 细胞中内源性前列腺特异性抗原基因的表达。Atraric acid 还能抑制 NO 和细胞因子的合成,抑制 MAPK-NFκB 信号通路。Atraric acid 可用于前列腺疾病和炎症性疾病的研究。
    Atraric acid
  • HY-N0807
    Swertiamarin

    獐牙菜苦苷

    Modulator 99.03%
    Swertiamarin 是一种口服有效的天然产物,具有降血糖、降血脂、抗风湿、抗氧化活性。Swertiamarin 可以调节促炎细胞因子、MMPNF-κB 水平并促进成骨细胞增殖。Swertiamarin 可以通过 Nrf2/HO-1 途径对四氯化碳诱导的大鼠肝毒性具有抗氧化和保肝作用。Swertiamarin 可以通过调节佐剂诱导的关节炎大鼠中的 JAK2/STAT3 转录因子来减弱炎症介质。Swertiamarin 可用于糖尿病、关节炎疾病的研究。
    Swertiamarin
  • HY-18620
    DZ2002 Inhibitor 99.68%
    DZ2002 是一种口服有效的、可逆的、低细胞毒性的 III 型 SAHH 抑制剂 (Ki=17.9 nM),具有较好的免疫抑制活性。DZ2002 能通过逆转各种细胞类型的促纤维化表型来防止实验性皮肤纤维化的发展。DZ2002 可用于自身免疫性疾病,如狼疮综合征和系统性硬化症的研究。
    DZ2002
  • HY-U00450
    4-O-Methyl honokiol

    4--O-甲基和厚朴酚

    Inhibitor 98.18%
    4-O-Methyl honokiol 是从厚朴中分离到的木脂素类化合物,为 PPARγ 的激动剂,可抑制 NF-κB 的活性,用于癌症,炎症等研究。
    4-O-Methyl honokiol
  • HY-B1278
    D-α-Tocopherol acetate

    生育酚乙酸酯

    Inhibitor 98.32%
    D-α-Tocopherol acetate (D-Vitamin E acetate) 可水解为 d-α-生育酚 (VE) 并被小肠吸收。
    D-α-Tocopherol acetate
  • HY-Y0148
    10-Hydroxydecanoic acid

    10-羟基癸酸

    Inhibitor 98.77%
    10-Hydroxydecanoic acid (10-HDAA) 是 10-hydroxy-trans-2-decenoic acid 的饱和脂肪酸,可以从蜂王浆中分离得到。10-Hydroxydecanoic acid 具有多种生物活性,包括抗炎、杀虫、抗疟、抗利什曼原虫以及增强抗原特异性免疫反应。 10-Hydroxydecanoic acid 的抗炎作用主要通过抑制 NF-κB 的激活和干扰素调节因子 1 (IRF-1) 的翻译,减少炎症细胞中白细胞介素 6 (IL-6) 和一氧化氮 (NO) 的产生。此外,10-Hydroxydecanoic acid 还通过 p53-自噬 (autophagy) 途径和 p53-NLRP3 通路减轻神经炎症反应。最后,10-Hydroxydecanoic acid 通过促进微折叠细胞对抗原的有效摄取,增强抗原特异性免疫反应。
    10-Hydroxydecanoic acid
  • HY-N0119
    Naringin Dihydrochalcone

    柚皮苷二氢查尔酮

    Inhibitor 99.65%
    Naringin Dihydrochalcone是由柚皮苷衍生的人造甜味剂。 柚皮苷是从番茄,葡萄柚和许多其他柑橘类水果中获得的主要黄烷酮糖苷。 柚皮素表现出抗氧化,抗炎和抗细胞凋亡等生物活性。Naringin 可抑制 NF-κB 信号通路。
    Naringin Dihydrochalcone
  • HY-N0106
    (Rac)-Salvianic acid A sodium

    (Rac)-丹参素钠

    Inhibitor ≥98.0%
    (Rac)-Salvianic acid A sodium 是 Salvianic acid A (HY-N1913) 的外消旋体。Salvianic acid A 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路,也可激活线粒体 (Mitochondrial Metabolism) 抗氧化防御系统。Salvianic acid A 具有抗炎、抗氧化、抗凋亡 (Apoptosis) 等作用,具有用于炎症和心脑血管等疾病研究的潜力。
    (Rac)-Salvianic acid A sodium
  • HY-13010
    Laquinimod

    拉喹莫德

    Inhibitor 99.96%
    Laquinimod (ABR-215062) 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod 减少星形胶质细胞 NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。
    Laquinimod
  • HY-N2543
    Damascenone Inhibitor 99.26%
    Damascenone ((E/Z)-Damascenone) 源于 Epipremnum pinnatum 的具有抗炎活性的活性化合物。Damascenone 是E- 和Z- 异构体大马士革酮的混合物。
    Damascenone
  • HY-107802
    Breviscapine

    灯盏花素

    Inhibitor
    Breviscapine 是灯盏花的黄酮类粗提取物,85% 以上为有效成分,灯盏花乙素。Breviscapine 具有广泛的心血管药理活性,如增加血流量、改善微循环、扩张血管、降低血液粘度、促进纤溶、抑制血小板聚集、血栓形成等。Breviscapine 已用于脑梗塞及其后遗症、脑血栓、冠心病、心绞痛的研究中发挥出优良效力。
    Breviscapine
  • HY-N1410
    Triacetylresveratrol

    三乙酰基白藜芦醇

    Inhibitor 99.58%
    Triacetylresveratrol 是 Resveratrol 的乙酰化类似物。Triacetylresveratrol 降低 STAT3NF-κB 磷酸化。具有抗癌作用。
    Triacetylresveratrol
  • HY-N0631
    Cornuside

    山茱萸新苷

    Inhibitor 99.99%
    Cornuside 是一种从山茱萸 (Cornus officinalis Sieb. et Zucc.) 的果实中分离出的环烯醚萜苷,山茱萸是一种传统的东方医药,可用于炎症疾病的研究和促进血液循环。 Cornuside 通过下调 MAPKNF-κB 信号通路抑制肥大细胞介导的过敏反应。Cornuside 的体内和体外抗过敏作用表明该活性分子有用于炎性过敏性疾病中的潜能。
    Cornuside
  • HY-P1847A
    IKKγ NBD Inhibitory Peptide TFA 98.20%
    IKKγ NBD 抑制肽 TFA 是一种高度特异性的 NF-κB 抑制剂。IKKγ NBD 抑制肽 TFA 通过阻断 IKKγ/NEMO 结合域 (NBD) 与 IKKα 和 IKKβ 之间的相互作用,而阻断 TNF-α 诱导的 NF-κB 激活。IKKγ NBD 抑制肽 TFA 可显著降低炎症、改善脑缺血所致的神经功能缺损。
    IKKγ NBD Inhibitory Peptide TFA
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.